The First Comprehensive Foundation Model AI for Abdomen CT
FDA-cleared comprehensive abdomen CT triage powered by Aidoc’s CARE™ foundation model. The solution brings 11 newly cleared indications and three previously cleared indications together into a single workflow to help prioritize critical cases and overcome Emergency Department (ED) bottlenecks.
Comprehensive Triage
CARE™-powered coverage for 14 acute indications. One worklist. AI surfaces acute cases earlier, helping patients get care faster.
The Challenge
The Failure of First-In, First-Out
We know ED crowding is structural; the real failure point is the linear workflow. In a traditional queue, “urgent” imaging is just a label, not a process. Without comprehensive AI, critical abdominal cases sit in line behind routine exams, indistinguishable until the radiologist opens the scan.
Comprehensive AI provides a safety net for busy EDs. It doesn’t just manage the queue; it surfaces acute cases earlier, enabling timely decision-making even when volumes are high.
Key Takeaway:
Staffing growth is too slow to match the surge in demand. With facility capacity fixed and volume rising, the only immediate operational lever is shifting from linear queues to acuity-based prioritization.
The Bottleneck
The Bottleneck Isn’t the Scan, It’s the Queue
Abdomen CT imaging drives a major portion of ED workload. Unlike routine exams, this high-volume category represents the critical intersection of complexity and demand.
+
=
Unspecified abdominal pain is one of the most common ED complaints. As abdomen CT volumes rise, the absence of AI-driven prioritization forces radiologists into a first-in, first-out queue with no visibility into which cases are truly urgent. Critical findings are buried behind normal scans, delaying care when time matters most. At this scale, even small delays compound into meaningful clinical risk and operational strain.
“The ability to bring key acute conditions together into a single workflow is a fundamental shift in how radiology departments operate. We’ve integrated numerous AI tools across our imaging operations, but this comprehensive triage solution can directly address core challenges in the field.”
Heidi Beilis, MD, FACR
Chief Medical Officer of Diagnostics at WellSpan Health
FDA Cleared
14 Acute Indications.
One Comprehensive Triage Solution.
11 newly cleared indications. Three previously cleared. Building on its FDA Breakthrough Device designation, this clearance validates the industry’s first comprehensive foundation-model approach to AI.
Comprehensive triage builds on point solutions by providing the breadth, accuracy, and workflow context required to drive consistent prioritization and diagnostic acceleration.
Clinical Proof
Comprehensive Acute Coverage with High Accuracy
The FDA clearance was supported by a rigorous multi-site pivotal study. The results were clear: the CARE™ foundation model delivers markedly improved signal quality, with roughly an order-of-magnitude reduction in false alerts compared to prior generation point solutions.
High Specificity Matters
It means that when a case jumps to the top of the list, it most likely belongs there. Prioritization only works if the signal is clean and physicians trust it.
Performance Metrics
Sensitivity
Up to 98.5%
Specificity
Up to 99.7%
Note: Performance assessed during FDA clearance process. Performance may vary by indication.
Stay informed on new clinical indications.
Validated on Millions. Deployed at over 1,600 Sites.
FDA clearance is the starting line. Real-world impact is the finish line. We’re already embedded in the workflows of over 1,600 medical centers, analyzing 60 million patient cases per year, turning the “Comprehensive Era” from a concept into a daily clinical reality.
Medical Centers
Scans Analyzed per Year
Coverage is Nothing Without Delivery.
Flagging a pathology isn’t what changes outcomes, it’s acting on it. Disconnected models create disconnected workflows. This solution integrates directly into native workflows and systems via our aiOS to sustain AI performance and impact at foundation-model scale.
Ingest
AI scans pixel data in the background instantly.
Orchestrate
The system identifies the exam and order characteristics and applies the correct algorithms.
Prioritize
AI-suspected acute cases are flagged ahead of the queue.
Monitor
AI-powered analytics provide a transparent view of performance and turnaround times.
“Health systems are increasingly looking to AI to improve access and tackle their most pressing priorities. With CARE, we knew breadth alone wasn’t enough. We were committed to meeting the safety and quality threshold required for real-world clinical use. This FDA clearance, combining unprecedented breadth and accuracy, marks a new era for clinical AI.”
Elad Walach
CEO and Co-founder, Aidoc
Step Into the Comprehensive Era
Comprehensive Abdomen CT
FDA Cleared
Expanded Chest Indications
Coming Soon
Caution: Investigational device. Limited by United States law to investigational use.
Pixel-to-Report Auto-Drafting
In Development
Caution: Investigational device. Limited by United States law to investigational use.